Evaluation of Nano-curcumin effects on expression levels of virulence genes and biofilm production of multidrug-resistant Pseudomonas aeruginosa isolated from burn wound infection in Tehran, Iran

References

• Church D, Elsayed S, Reid O, Winston B, Lindsay R. Burn wound infections. Clin Microbiol Rev. 2006;19(2):403–434. doi:10.1128/CMR.19.2.403-434.200616614255
   PubMed Web of Science ®Google Scholar
• Vindenes H, Bjerknes R. Microbial colonization of large wounds. Burns. 1995;21(8):575–579.8747728
   PubMed Web of Science ®Google Scholar
• Fallah F, Borhan RS, Hashemi A. Detection of bla(IMP) and bla(VIM) metallo-β-lactamases genes among Pseudomonas aeruginosa strains. Int J Burns Trauma. 2013;3(2):122–124.23638331
   PubMedGoogle Scholar
• Alexander JW. Mechanism of immunologic suppression in burn injury. J Trauma Acute Care Surg. 1990;30:70–74. doi:10.1097/00005373-199012001-00017
   Google Scholar
• Grogan JB. Altered neutrophil phagocytic function in burn patients. J Trauma. 1976;16(9):734–738.827620
   PubMedGoogle Scholar
• Clark NM, Patterson J, Lynch JP. Antimicrobial resistance among gram-negative organisms in the intensive care unit. Curr Opin Crit Care. 2003;9(5):413–423.14508155
   PubMedGoogle Scholar
• Dalamaga M, Karmaniolas K, Chavelas C, Liatis S, Matekovits H, Migdalis I. Stenotrophomonas maltophilia: a serious and rare complication in patients suffering from burns. Burns. 2003;29(7):711–713.14556730
   PubMed Web of Science ®Google Scholar
• Bahramian A, Khoshnood S, Shariati A, Doustdar F, Chirani AS, Heidary M. Molecular characterization of the pilS2 gene and its association with the frequency of Pseudomonas aeruginosa plasmid pKLC102 and PAPI-1 pathogenicity island. Infect Drug Resist. 2019;12:221. doi:10.2147/IDR.S18852730666137
   PubMed Web of Science ®Google Scholar
• Shariati A, Fallah F, Pormohammad A, et al. The possible role of bacteria, viruses, and parasites in initiation and exacerbation of irritable bowel syndrome. J Cell Physiol. 2019;234(6):8550–8569. doi:10.1002/jcp.2782830480810
   PubMed Web of Science ®Google Scholar
• Jafari M, Fallah F, Borhan RS, et al. The first report of CMY, aac (6′)-Ib and 16S rRNA methylase genes among Pseudomonas aeruginosa isolates from Iran. Archiv Pediatric Infect Dis. 2013;1(3):109–112. doi:10.5812/pedinfect.11392
   Google Scholar
• Taherpour A, Hashemi A, Erfanimanesh S, Taki E. Efficacy of methanolic extract of green and black teas against extended-spectrum β-Lactamase-producing Pseudomonas aeruginosa. Pak J Pharm Sci. 2016;29(4):1257–1261.27393439
   PubMed Web of Science ®Google Scholar
• Li X-Z, Nikaido H, Poole K. Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1995;39(9):1948–1953. doi:10.1128/aac.39.9.19488540696
   PubMed Web of Science ®Google Scholar
• Balasubramanian D, Schneper L, Merighi M, et al. The regulatory repertoire of Pseudomonas aeruginosa AmpC ß-lactamase regulator AmpR includes virulence genes. PLoS One. 2012;7(3):e34067. doi:10.1371/journal.pone.003406722479525
   PubMed Web of Science ®Google Scholar
• Ishida H, Ishida Y, Kurosaka Y, Otani T, Sato K, Kobayashi H. In vitro and in vivo activities of levofloxacin against biofilm-producing Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1998;42(7):1641–1645.9660997
   PubMed Web of Science ®Google Scholar
• Ardehali SH, Azimi T, Owrang M, Aghamohammadi N, Azimi L. Role of efflux pumps in reduced susceptibility to tigecycline in Acinetobacter baumannii. New Microbes New Infecti. 2019;100547. doi:10.1016/j.nmni.2019.100547
   Google Scholar
• Stoodley P, Sauer K, Davies D, Costerton JW. Biofilms as complex differentiated communities. Ann Rev Microbiol. 2002;56(1):187–209. doi:10.1146/annurev.micro.56.012302.16070512142477
   PubMed Web of Science ®Google Scholar
• Shigeta M, Tanaka G, Komatsuzawa H, Sugai M, Suginaka H, Usui T. Permeation of antimicrobial agents through Pseudomonas aeruginosa biofilms: a simple method. Chemotherapy. 1997;43(5):340–345. doi:10.1159/0002395879309367
   PubMed Web of Science ®Google Scholar
• Sharahi JY, Azimi T, Shariati A, Safari H, Tehrani MK, Hashemi A. Advanced strategies for combating bacterial biofilms. J Cell Physiol. 2019. doi:10.1002/jcp.28225
   PubMed Web of Science ®Google Scholar
• Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as “Curecumin”: from kitchen to clinic. Biochem Pharmacol. 2008;75(4):787–809. doi:10.1016/j.bcp.2007.08.01617900536
   PubMed Web of Science ®Google Scholar
• Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. Aaps J. 2013;15(1):195–218. doi:10.1208/s12248-012-9432-823143785
   PubMed Web of Science ®Google Scholar
• Moshe M, Lellouche J, Banin E. Curcumin: a natural antibiofilm agent. In: Mendez-Vilas A, editor. Science and Technology Against Microbial Pathogens Singapore: World Scientific; 2011:89–93.
   Google Scholar
• Flora G, Gupta D, Tiwari A. Nanocurcumin: a promising therapeutic advancement over native curcumin. Crit Rev Ther Drug Carrier Syst. 2013;30(4):331–368.23662605
   PubMed Web of Science ®Google Scholar
• Basniwal RK, Buttar HS, Jain V, Jain N. Curcumin nanoparticles: preparation, characterization, and antimicrobial study. J Agric Food Chem. 2011;59(5):2056–2061. doi:10.1021/jf104402t21322563
   PubMed Web of Science ®Google Scholar
• Jabalameli F, Mirsalehian A, Khoramian B, et al. Evaluation of biofilm production and characterization of genes encoding type III secretion system among Pseudomonas aeruginosa isolated from burn patients. Burns. 2012;38(8):1192–1197. doi:10.1016/j.burns.2012.07.03022995427
   PubMed Web of Science ®Google Scholar
• Americal Association for Clinical Chemistry. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fourth Informational Supplement (M100-S24) Washington, DC: AACC; 2014 Available from: https://www.researchgate.net/file.PostFileLoader.html?id=59202a0696b7e4d462166956&assetKey=AS%3A496054988533760%401495280134033. Accessed June 28, 2019.
   Google Scholar
• Bahramian A, Shariati A, Azimi T, et al. First report of New Delhi metallo-β-lactamase-6 (NDM-6) among Klebsiella pneumoniae ST147 strains isolated from dialysis patients in Iran. Infect Genet Evol. 2019;69:142–145. doi:10.1016/j.meegid.2019.01.03030684646
   PubMed Web of Science ®Google Scholar
• Adahoun M, Al-Akhras M-AH, Jaafar MS, Bououdina M. Enhanced anti-cancer and antimicrobial activities of curcumin nanoparticles. Artif Cells, Nanomed Biotechnol. 2017;45(1):98–107. doi:10.3109/21691401.2015.112962826747522
   PubMed Web of Science ®Google Scholar
• Braydich-Stolle L, Hussain S, Schlager JJ, Hofmann M-C. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol Sci. 2005;88(2):412–419. doi:10.1093/toxsci/kfi25616014736
   PubMed Web of Science ®Google Scholar
• Shariati A, Azimi T, Ardebili A, et al. Insertional inactivation of oprD in carbapenem-resistant Pseudomonas aeruginosa strains isolated from burn patients in Tehran, Iran. New Microbes New Infecti. 2018;21:75–80. doi:10.1016/j.nmni.2017.10.013
   Google Scholar
• Dumas J-L, van Delden C, Perron K, Köhler T. Analysis of antibiotic resistance gene expression in Pseudomonas aeruginosa by quantitative real-time-PCR. FEMS Microbiol Lett. 2006;254(2):217–225. doi:10.1111/j.1574-6968.2005.00008.x16445748
   PubMed Web of Science ®Google Scholar
• Loo C-Y, Young PM, Cavaliere R, Whitchurch CB, Lee W-H, Rohanizadeh R. Silver nanoparticles enhance Pseudomonas aeruginosa PAO1 biofilm detachment. Drug Dev Ind Pharm. 2014;40(6):719–729. doi:10.3109/03639045.2013.78018223594297
   PubMed Web of Science ®Google Scholar
• Banar M, Emaneini M, Satarzadeh M, et al. Evaluation of mannosidase and trypsin enzymes effects on biofilm production of Pseudomonas aeruginosa isolated from burn wound infections. PLoS One. 2016;11(10):e0164622. doi:10.1371/journal.pone.016462227736961
   PubMed Web of Science ®Google Scholar
• Anvarinejad M, Japoni A, Rafaatpour N, et al. Burn Patients Infected With Metallo-Beta-Lactamase-Producing Pseudomonas aeruginosa: multidrug-Resistant Strains. Arch Trauma Res. 2014;3(2):e18182–e18182. doi:10.5812/atr.1818225147779
   PubMedGoogle Scholar
• Khosravi AD, Shafie F, Montazeri EA, Rostami S. The frequency of genes encoding exotoxin A and exoenzyme S in Pseudomonas aeruginosa strains isolated from burn patients. Burns. 2016;42(5):1116–1120. doi:10.1016/j.burns.2016.02.01227263417
   PubMed Web of Science ®Google Scholar
• Kesisoglou F, Panmai S, Wu Y. Nanosizing—oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev. 2007;59(7):631–644. doi:10.1016/j.addr.2007.05.00317601629
   PubMed Web of Science ®Google Scholar
• Roudashti S, Zeighami H, Mirshahabi H, Bahari S, Soltani A, Haghi F. Synergistic activity of sub-inhibitory concentrations of curcumin with ceftazidime and ciprofloxacin against Pseudomonas aeruginosa quorum sensing related genes and virulence traits. World J Microbiol Biotechnol. 2017;33(3):50. doi:10.1007/s11274-016-2195-028188589
   PubMed Web of Science ®Google Scholar
• Loo C-Y, Rohanizadeh R, Young PM, et al. Combination of silver nanoparticles and curcumin nanoparticles for enhanced anti-biofilm activities. J Agric Food Chem. 2015;64(12):2513–2522. doi:10.1021/acs.jafc.5b0455926595817
   PubMed Web of Science ®Google Scholar
• Krausz AE, Adler BL, Cabral V, et al. Curcumin-encapsulated nanoparticles as innovative antimicrobial and wound healing agent. Nanomedicine. 2015;11(1):195–206. doi:10.1016/j.nano.2014.09.00425240595
   PubMed Web of Science ®Google Scholar
• Oh H, Stenhoff J, Jalal S, Wretlind B. Role of efflux pumps and mutations in genes for topoisomerases II and IV in fluoroquinolone-resistant Pseudomonas aeruginosa strains. Microb Drug Resist. 2003;9(4):323–328. doi:10.1089/10766290332276274315000738
   PubMed Web of Science ®Google Scholar